SCHEMBL23707172

SCHEMBL23707172

CCc1c[nH]c2c(OC)cccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.69
HTR6 P50406 1/20 0.66
MTNR1A P48039 1/20 0.62
MTNR1B P49286 1/20 0.62
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
FTO Q9C0B1 1/20 0.48
ADRB3 P13945 4/20 0.46
ADRB1 P08588 3/20 0.46
ADRB2 P07550 2/20 0.46
DYRK1A Q13627 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NFATC1 O95644 1/20 0.45
GSK3B P49841 1/20 0.45
HDAC3 O15379 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24328225 0.85 HTR2A (0.68) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL5318994 0.84 HTR2A (0.62) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL25139456 0.84 MTNR1A (0.60) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL30708156 0.83 MTNR1A (0.62) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL21808835 0.83 MTNR1A (0.62) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL7867310 0.83 MTNR1A (0.66) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL1424902 0.82 HTR2A (1.00) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL26940351 0.82 HTR2A (0.64) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL837672 0.82 HTR6 (0.74) HTR2AHTR6MTNR1AMTNR1BKDM4E
SCHEMBL5791794 0.82 HTR2A (0.68) HTR2AHTR6MTNR1AMTNR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078201-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists Nimbus Saturn, Inc. (US) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078201-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists HIPK1, PDXK, IP6K1 HTR2A 570/4885HTR6 423/4885MTNR1A 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.